Effects of the interaction between carbogen and nicotinamide on R3230 Ac tumor blood flow in fischer 344 rats

Radiation Research

Volumn 155, Issue 5, 2001, Pages 724-733

  Braun, R D ^a   Lanzen, J L ^a   Turnage, J A ^a   Rosner, G ^a   Dewhirst, M W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOGEN; NICOTINAMIDE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTERIOLE; ARTICLE; BREATHING; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL NEOPLASM; FACE MASK; HEART RATE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RAT; TUMOR BLOOD FLOW;

EID: 0035019923     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0724:EOTIBC]2.0.CO;2     Document Type: Article

References (63)

1. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
2. 2 predicts survival in advanced cancer of the uterine cervix
3. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma
4. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
5. Oxygenation predicts radiation response and survival in patients with cervix cancer
6. Tumor hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix
7. Experimental data on the radiobiology of solid tumours
8. Heterogenous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma
9. Hypoxic fractions of solid tumors: Experimental techniques, methods of analysis, and a survey of existing data
10. The histologic structure of some human lung cancers and the possible implications of radiotherapy
11. Evidence for acutely hypoxic cells in mouse tumours and a possible mechanism of reoxygenation
12. On the nature of the radiobiologically hypoxic fraction in tumors
13. Intermittent blood flow in a murine tumor: Radiobiological effects
14. 2 of R3230Ac tumors in Fischer-344 rats
15. Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats
16. 2 histography
17. Changes in the oxygenation of head and neck tumors during carbogen breathing
18. The effects of nicotinamide and carbogen, individually or in combination, on RIF-1 tumour oxygenation
19. 3H mammary tumor
20. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: Importance of nicotinamide dose and pre-irradiation breathing time
21. Carbogen breathing during radiation therapy: The Radiation Therapy Oncology Group study
22. Hyperbaric oxygen improves tumor radiation response significantly more than carbogen/nicotinamide
23. Tumor radiosensitization by nicotinamide: A result of improved perfusion and oxygenation
24. Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumor
25. Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells
26. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing
27. Nicotinamide and carbogen: Major effect on the radiosensitivity of EMT6 and HRT 18 tumours
28. Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing
29. The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment
30. Carbogen and nicotinamide as radiosensitizers in a murine mammary carcinoma using conventional and accelerated radiotherapy
31. Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON)
32. Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: Hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide
33. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer
34. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide
35. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic in vivo: Importance of nicotinamide dose and pre-irradiation breathing time
36. Human tumor blood flow is enhanced by nicotinamide and carbogen breathing
37. The effects of altered arterial tensions of carbon dioxide and oxygen on cerebral blood flow and cerebral oxygen consumption of normal young men
38. Studies of the retinal circulation in man: Observations on vessel diameter, arteriovenous oxygen difference and mean circulation time
39. Skeletal muscle oxygen availability during respiratory acid-base disturbances in cats
40. Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined
41. 2 microcirculatory function and radiosensitivity
42. Arteriolar oxygenation in tumour and subcutaneous arterioles: Effects of inspired air oxygen content
43. Effect of carbogen breathing on tumour microregional blood flow in humans
44. 2 in tumors in response to carbogen breathing
45. The modification of blood flow in tumours and their supplying arteries by nicotinamide
46. The effects of hyperoxic and hypercarbic gases on tumour blood flow
47. The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation
48. A transparent access chamber for the rat dorsal skin fold
49. Nicotinamide exerts different acute effects on microcirculatory function and tissue oxygenation in rat tumors
50. Possible mechanisms involved in tumor radiosensitization following nicotinamide administration
51. The radiosensitizer nicotinamide inhibits arterial vasoconstriction
52. Nicotinamide-inhibited vasoconstriction: Lack of dependence on agonist signalling pathways
53. Nicotinamide pharmacokinetics in humans and mice: A comparative assessment and the implications for radiotherapy
54. Effects of diethylamine/nitric oxide on blood perfusion and oxygenation in the R3230Ac mammary carcinoma
55. Nicotinamide can lower tumor interstitial fluid pressure: Mechanistic and therapeutic implications
56. Myogenic response gradient in an arteriolar network
57. Effects of bradykinin on the hemodynamics of tumor and granulating normal tissue microvasculature
58. Geometric resistance to blood flow in solid tumors perfused ex vivo: Effects of tumor size and perfusion pressure
59. Reduction in tumor blood flow in skin flap tumor after hydralazine is not due to a vascular steal phenomenon
60. The effect of nicotinamide on microregional blood flow within tumours assessed using laser Doppler probes
61. 2
62. Arteriolar oxygenation in tumour and subcutaneous arterioles: Effects of inspired air oxygen content
63. Mechanism of action of the selective tumor radiosensitizer nicotinamide